Options
Schön, Michael P.
Loading...
Preferred name
Schön, Michael P.
Official Name
Schön, Michael P.
Alternative Name
Schön, M. P.
Schoen, M.
Schoen, Michael P.
Schoen, Michael Peter
Schön, Michael P.
Schön, M.
Schoen, M.P.
Schön, Michael
Schoen, Michael
Now showing 1 - 10 of 69
2015Conference Abstract [["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Experimental Dermatology"],["dc.bibliographiccitation.volume","24"],["dc.contributor.author","Buhl, Timo"],["dc.contributor.author","Ikoma, Akihiko"],["dc.contributor.author","Cevikbas, F."],["dc.contributor.author","Kempkes, Cordula"],["dc.contributor.author","Sulk, Mathias"],["dc.contributor.author","Akiyama, Tasuku"],["dc.contributor.author","Carstens, Earl"],["dc.contributor.author","Schoen, Michael Peter"],["dc.contributor.author","Elias, P. M."],["dc.contributor.author","Coughlin, S."],["dc.contributor.author","Steinhoff, Martin"],["dc.date.accessioned","2018-11-07T10:00:07Z"],["dc.date.available","2018-11-07T10:00:07Z"],["dc.date.issued","2015"],["dc.format.extent","E1"],["dc.identifier.isi","000351939000002"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/37729"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-blackwell"],["dc.publisher.place","Hoboken"],["dc.relation.conference","42nd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF)"],["dc.relation.eventlocation","Ulm, GERMANY"],["dc.relation.issn","1600-0625"],["dc.relation.issn","0906-6705"],["dc.title","Epidermal PAR2 overexpression causes atopic dermatitis-like skin disease: neuro-epidermal communication"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]Details WOS2012Journal Article Discussion [["dc.bibliographiccitation.firstpage","1035"],["dc.bibliographiccitation.issue","7"],["dc.bibliographiccitation.journal","Clinical Infectious Diseases"],["dc.bibliographiccitation.lastpage","1036"],["dc.bibliographiccitation.volume","54"],["dc.contributor.author","Bader, Oliver"],["dc.contributor.author","Weig, Michael S."],["dc.contributor.author","Gross, Uwe"],["dc.contributor.author","Schoen, Michael Peter"],["dc.contributor.author","Mempel, Martin"],["dc.contributor.author","Buhl, Timo"],["dc.date.accessioned","2018-11-07T09:11:58Z"],["dc.date.available","2018-11-07T09:11:58Z"],["dc.date.issued","2012"],["dc.identifier.doi","10.1093/cid/cir943"],["dc.identifier.isi","000301296200029"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/26841"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Oxford Univ Press Inc"],["dc.relation.issn","1058-4838"],["dc.title","A 32-Year-Old Man With Ulcerative Mucositis, Skin Lesions, and Nail Dystrophy"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.subtype","letter_note"],["dspace.entity.type","Publication"]]Details DOI WOS2011Conference Abstract [["dc.bibliographiccitation.issue","9"],["dc.bibliographiccitation.journal","JDDG Journal der Deutschen Dermatologischen Gesellschaft"],["dc.bibliographiccitation.volume","9"],["dc.contributor.author","Buhl, Timo"],["dc.contributor.author","Richter, A."],["dc.contributor.author","Haas, E."],["dc.contributor.author","Holzkamp, R."],["dc.contributor.author","Emmert, Steffen"],["dc.contributor.author","Schoen, Michael Peter"],["dc.contributor.author","Haenssle, Holger Andreas"],["dc.date.accessioned","2018-11-07T08:52:36Z"],["dc.date.available","2018-11-07T08:52:36Z"],["dc.date.issued","2011"],["dc.format.extent","781"],["dc.identifier.isi","000294596900143"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/22210"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-blackwell"],["dc.publisher.place","Malden"],["dc.relation.issn","1610-0379"],["dc.title","Radiotherapy in thyroid Eye Disease: Ocurrence of pigmented Basal Cell Carcinomas with 15 years Latency"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]Details WOS2016Journal Article Discussion [["dc.bibliographiccitation.issue","7"],["dc.bibliographiccitation.journal","Clinical Infectious Diseases"],["dc.bibliographiccitation.volume","62"],["dc.contributor.author","Moessner, Rotraut"],["dc.contributor.author","Diering, Nina"],["dc.contributor.author","Bader, Oliver"],["dc.contributor.author","Forkel, Susann"],["dc.contributor.author","Overbeck, Tobias R."],["dc.contributor.author","Gross, Uwe"],["dc.contributor.author","Grimbacher, Bodo"],["dc.contributor.author","Schoen, Michael Peter"],["dc.contributor.author","Buhl, Timo"],["dc.date.accessioned","2018-11-07T10:16:10Z"],["dc.date.available","2018-11-07T10:16:10Z"],["dc.date.issued","2016"],["dc.identifier.doi","10.1093/cid/ciw020"],["dc.identifier.isi","000374248700026"],["dc.identifier.pmid","26787170"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/40985"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Oxford Univ Press Inc"],["dc.relation.issn","1537-6591"],["dc.relation.issn","1058-4838"],["dc.title","Ruxolitinib Induces Interleukin 17 and Ameliorates Chronic Mucocutaneous Candidiasis Caused by STAT1 Gain-of-Function Mutation"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.subtype","letter_note"],["dspace.entity.type","Publication"]]Details DOI PMID PMC WOS2014Conference Abstract [["dc.bibliographiccitation.journal","JDDG Journal der Deutschen Dermatologischen Gesellschaft"],["dc.bibliographiccitation.volume","12"],["dc.contributor.author","Haenssle, Holger Andreas"],["dc.contributor.author","Hoffmann, S."],["dc.contributor.author","Buhl, Timo"],["dc.contributor.author","Emmert, Steffen"],["dc.contributor.author","Schoen, Michael Peter"],["dc.contributor.author","Rosenberger, Albert"],["dc.date.accessioned","2018-11-07T09:36:15Z"],["dc.date.available","2018-11-07T09:36:15Z"],["dc.date.issued","2014"],["dc.format.extent","15"],["dc.identifier.isi","000340532500037"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/32571"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-blackwell"],["dc.publisher.place","Hoboken"],["dc.relation.issn","1610-0387"],["dc.relation.issn","1610-0379"],["dc.title","Determination of Patient Characteristics in Specific Melanoma Subtypes by means of a Prospective Observational Study"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]Details WOS2015Journal Article [["dc.bibliographiccitation.firstpage","37"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","JDDG Journal der Deutschen Dermatologischen Gesellschaft"],["dc.bibliographiccitation.lastpage","45"],["dc.bibliographiccitation.volume","13"],["dc.contributor.author","Haenssle, Holger Andreas"],["dc.contributor.author","Hoffmann, Saskia"],["dc.contributor.author","Buhl, Timo"],["dc.contributor.author","Emmert, Steffen"],["dc.contributor.author","Schoen, Michael Peter"],["dc.contributor.author","Bertsch, Hans Peter"],["dc.contributor.author","Rosenberger, Albert"],["dc.date.accessioned","2018-11-07T10:04:00Z"],["dc.date.available","2018-11-07T10:04:00Z"],["dc.date.issued","2015"],["dc.description.abstract","BackgroundCertain melanoma histotypes carry a worse prognosis than others. We aimed to identify patient related factors associated with specific melanoma histotypes. Patients and methodsSingle center study including 347 melanoma patients, prospectively assessed for 22 variables leading to a database of more than 7600 features. ResultsMelanomas were histologically categorized as superficial spreading (SSM, 70.6%), nodular (NM; 12.7%), acrolentiginous (ALM; 4.0%), lentigo maligna (LMM; 3.8%), or unclassified melanoma (UCM; 8.9%). Well recognized melanoma risk indicators (i.e. many atypical nevi, freckles, previous melanoma), were significantly associated with SSM and LMM histotypes. NM and ALM patients carried significantly less common and/or atypical nevi. NM were mostly self-detected or detected by relatives. In contrast, SSM, LMM, and ALM were most frequently detected by dermatologists. NM and UCM were preferentially located on poorly observable sites, SSM on the lower limbs, ALM on plantar sites, and LMM on the head and neck. ALM and LMM patients were significantly older than other patients. A multinomial logistic model was designed to predict a certain melanoma histotype (overall accuracy 81%), which could be helpful to focus the attention of clinicians or may be integrated into fully automated diagnostic algorithms. ConclusionsMelanoma histotypes show significant differences regarding patients' characteristics."],["dc.identifier.doi","10.1111/ddg.12561"],["dc.identifier.isi","000347445900006"],["dc.identifier.pmid","25640492"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/38598"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-blackwell"],["dc.relation.issn","1610-0387"],["dc.relation.issn","1610-0379"],["dc.title","Assessment of melanoma histotypes and associated patient related factors: Basis for a predictive statistical model"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]Details DOI PMID PMC WOS2011Conference Abstract [["dc.bibliographiccitation.issue","9"],["dc.bibliographiccitation.journal","JDDG Journal der Deutschen Dermatologischen Gesellschaft"],["dc.bibliographiccitation.volume","9"],["dc.contributor.author","Haenssle, Holger Andreas"],["dc.contributor.author","Buhl, Timo"],["dc.contributor.author","Hansen-Hagge, Christian"],["dc.contributor.author","Korpas, Bianca"],["dc.contributor.author","Kaune, Kjell Matthias"],["dc.contributor.author","Rosenberger, Albert"],["dc.contributor.author","Emmert, Steffen"],["dc.contributor.author","Schoen, M."],["dc.date.accessioned","2018-11-07T08:52:36Z"],["dc.date.available","2018-11-07T08:52:36Z"],["dc.date.issued","2011"],["dc.format.extent","766"],["dc.identifier.isi","000294596900091"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/22209"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-blackwell"],["dc.publisher.place","Malden"],["dc.relation.issn","1610-0379"],["dc.title","Melanoma Early Detction with the Algorithm DynaMel: Combined dermatoscopic dynamic Evaluation and static Criteria"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]Details WOS2020Journal Article [["dc.bibliographiccitation.firstpage","795"],["dc.bibliographiccitation.issue","8"],["dc.bibliographiccitation.journal","Journal der Deutschen Dermatologischen Gesellschaft"],["dc.bibliographiccitation.lastpage","807"],["dc.bibliographiccitation.volume","18"],["dc.contributor.author","Schön, Michael P."],["dc.contributor.author","Berking, Carola"],["dc.contributor.author","Biedermann, Tilo"],["dc.contributor.author","Buhl, Timo"],["dc.contributor.author","Erpenbeck, Luise"],["dc.contributor.author","Eyerich, Kilian"],["dc.contributor.author","Eyerich, Stefanie"],["dc.contributor.author","Ghoreschi, Kamran"],["dc.contributor.author","Goebeler, Matthias"],["dc.contributor.author","Ludwig, Ralf J."],["dc.contributor.author","Schäkel, Knut"],["dc.contributor.author","Schilling, Bastian"],["dc.contributor.author","Schlapbach, Christoph"],["dc.contributor.author","Stary, Georg"],["dc.contributor.author","Stebut, Esther"],["dc.contributor.author","Steinbrink, Kerstin"],["dc.date.accessioned","2021-04-14T08:24:09Z"],["dc.date.available","2021-04-14T08:24:09Z"],["dc.date.issued","2020"],["dc.description.abstract","Summary The COVID‐19 pandemic caused by SARS‐CoV‐2 has far‐reaching direct and indirect medical consequences. These include both the course and treatment of diseases. It is becoming increasingly clear that infections with SARS‐CoV‐2 can cause considerable immunological alterations, which particularly also affect pathogenetically and/or therapeutically relevant factors. Against this background we summarize here the current state of knowledge on the interaction of SARS‐CoV‐2/COVID‐19 with mediators of the acute phase of inflammation (TNF, IL‐1, IL‐6), type 1 and type 17 immune responses (IL‐12, IL‐23, IL‐17, IL‐36), type 2 immune reactions (IL‐4, IL‐13, IL‐5, IL‐31, IgE), B‐cell immunity, checkpoint regulators (PD‐1, PD‐L1, CTLA4), and orally druggable signaling pathways (JAK, PDE4, calcineurin). In addition, we discuss in this context non‐specific immune modulation by glucocorticosteroids, methotrexate, antimalarial drugs, azathioprine, dapsone, mycophenolate mofetil and fumaric acid esters, as well as neutrophil granulocyte‐mediated innate immune mechanisms. From these recent findings we derive possible implications for the therapeutic modulation of said immunological mechanisms in connection with SARS‐CoV‐2/COVID‐19. Although, of course, the greatest care should be taken with patients with immunologically mediated diseases or immunomodulating therapies, it appears that many treatments can also be carried out during the COVID‐19 pandemic; some even appear to alleviate COVID‐19."],["dc.identifier.doi","10.1111/ddg.14169"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/81179"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-399"],["dc.relation.eissn","1610-0387"],["dc.relation.issn","1610-0379"],["dc.rights","This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes."],["dc.title","COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]Details DOI2009Journal Article [["dc.bibliographiccitation.firstpage","E21"],["dc.bibliographiccitation.issue","5"],["dc.bibliographiccitation.journal","Clinical Lymphoma & Myeloma"],["dc.bibliographiccitation.lastpage","E24"],["dc.bibliographiccitation.volume","9"],["dc.contributor.author","Buhl, Timo"],["dc.contributor.author","Bertsch, Hans P."],["dc.contributor.author","Kaune, Kjell M."],["dc.contributor.author","Mitteldorf, Christina"],["dc.contributor.author","Schön, Michael P."],["dc.contributor.author","Kretschmer, Lutz"],["dc.date.accessioned","2021-06-01T10:48:52Z"],["dc.date.available","2021-06-01T10:48:52Z"],["dc.date.issued","2009"],["dc.identifier.doi","10.3816/CLM.2009.n.079"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/86081"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-425"],["dc.relation.issn","1557-9190"],["dc.title","Low-Dose Gemcitabine Efficacious in Three Patients With Tumor-Stage Mycosis Fungoides"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]Details DOI2014Conference Abstract [["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Experimental Dermatology"],["dc.bibliographiccitation.volume","23"],["dc.contributor.author","Buhl, Timo"],["dc.contributor.author","Braun, Alexander"],["dc.contributor.author","Forkel, Susann"],["dc.contributor.author","Möbius, Wiebke"],["dc.contributor.author","van Werven, Lars"],["dc.contributor.author","Jahn, Olaf"],["dc.contributor.author","Rezaei-Ghaleh, Nasrollah"],["dc.contributor.author","Zweckstetter, Markus"],["dc.contributor.author","Mempel, Martin"],["dc.contributor.author","Schoen, Michael Peter"],["dc.contributor.author","Haenssle, Holger Andreas"],["dc.date.accessioned","2018-11-07T09:43:01Z"],["dc.date.available","2018-11-07T09:43:01Z"],["dc.date.issued","2014"],["dc.format.extent","E32"],["dc.identifier.isi","000332335500205"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/34085"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-blackwell"],["dc.publisher.place","Hoboken"],["dc.relation.eventlocation","Cologne, GERMANY"],["dc.relation.issn","1600-0625"],["dc.relation.issn","0906-6705"],["dc.title","Routes of internalization for Melan-A/TAT fusion peptides differ considerably between human dendritic cells and other non-phagocytic cell types"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]Details WOS